In 2/3 Generics Cases, Mylan Execs Allowed To Revoke 5th

By Bryan Koenig · October 26, 2026, 7:21 PM EDT

A Connecticut federal judge carved a different path Friday for two later generic-drug price-fixing cases from state attorneys general, allowing Mylan executives to revoke their previous invocation of the Fifth Amendment...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Case Number

2:16-md-02724

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 05, 2016

Case Title

Connecticut et al v. Aurobindo Pharma USA, Inc. et al

Case Number

3:16-cv-02056

Court

Connecticut

Nature of Suit

410 Anti-Trust

Date Filed

December 15, 2016

Case Title

Connecticut et al v. Teva Pharmaceuticals USA, Inc.

Case Number

3:19-cv-00710

Court

Connecticut

Nature of Suit

410 Anti-Trust

Date Filed

May 10, 2019

Case Title

Connecticut et al v. Sandoz, Inc. et al

Case Number

3:20-cv-00802

Court

Connecticut

Nature of Suit

410 Anti-Trust

Date Filed

June 10, 2020